Overview of Dr. Dahi
Dr. Parastoo Dahi is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from Azad University and has been in practice 16 years. She is one of 464 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. She has more than 100 publications and over 500 citings.
Office
Memorial Sloan Kettering Cancer Center New York
1275 York Avenue
New York, NY 10021- Is this information wrong?
Education & Training
SUNY Downstate Health Sciences UniversityFellowship, Hematology and Medical Oncology, 2008 - 2011- SUNY Health Science Center at BrooklynResidency, Internal Medicine, 2005 - 2008
Azad UniversityClass of 2001
Certifications & Licensure
FL State Medical License 2021 - Present
NJ State Medical License 2018 - 2025
CT State Medical License 2023 - 2024
NY State Medical License 2011 - 2024- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Phase I Study of Bendamustine and Melphalan Conditioning and Autologous Stem Cell Transplantation for Treatment of Multiple Myeloma and Relapsed/Refractory B-cell Lymphoma in Elderly Patients Start of enrollment: 2017 Nov 20
- Dose Escalation & Expansion Study of Oral VRx-3996 & Valganciclovir in Subjects With EBV-Associated Lymphoid Malignancies Start of enrollment: 2018 Mar 29
Roles: Contact
- HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903 Start of enrollment: 2021 Oct 25
Roles: Contact
- Join now to see all
Publications & Presentations
PubMed
- Comparison of whole-genome and immunoglobulin-based circulating tumor DNA assays in diffuse large B-cell lymphoma.Reid W Merryman, Justin Rhoades, Kan Xiong, Robert A Redd, Katherine Antel, Hyun Hwan An, Mikaela McDonough, Liliana Guerrero, Andela Crnjac, Sainetra Sridhar, Timothy...> ;Hemasphere. 2024 Apr 1
- BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cel...Robert Stuver, Agrima Mian, Samantha Brown, Sean Devlin, Paolo F Caimi, Stephanie Chinapen, Parastoo Dahi, Robert Dean, Zachary D Epstein-Peterson, Brian Hill, Steven ...> ;American Journal of Hematology. 2024 Mar 25
- Transplantation and Cellular Therapy for Older Adults-The MSK Approach.Richard J Lin, Parastoo B Dahi, Beatriz Korc-Grodzicki, Armin Shahrokni, Ann A Jakubowski, Sergio A Giralt> ;Current Hematologic Malignancy Reports. 2024 Apr 1
- Join now to see all
Journal Articles
- Strategies to Improve Outcomes of Autologous Hematopoietic Cell Transplant in LymphomaParastoo B Dahi, Hillard M Lazarus, Sergio A Giralt, Craig S Sauter, Nature
- End-of-Life Care for Older AML Patients Relapsing After Allogeneic Stem Cell Transplant at a Dedicated Cancer CenterSergio A Giralt, Virginia M Klimek, Richard J Lin, Ann A Jakubowski, Esperanza B Papadopoulos, Parastoo B Dahi, Nature
Abstracts/Posters
- Delayed Neutrophil Engraftment in Patients Receiving Daratumumab As Part of Their First Induction Regimen for Multiple MyelomaParastoo B. Dahi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- MSKCC Early Experience Using Radiotherapy As a Bridging Strategy for Relapsed Diffuse Large B Cell Lymphoma before CD19 CAR T TherapyParastoo B. Dahi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Early Experience Using Radiotherapy As a Salvage Treatment for Relapsed or Refractory Non-Hodgkin Lymphomas Following CD19 Chimeric Antigen Receptor Modified T-Cell Th...Parastoo B. Dahi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- Double-Unit Cord Blood (CB) Transplantation with Haplo-Identical CD34+ Cells (haplo-dCBT) May Speed Neutrophil Recovery Although Successful Bridging Is Contingent on C...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- A Simple Geriatric Vulnerability Index for Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- PD-1 Blockade with Pembrolizumab for Classical Hodgkin Lymphoma after Autologous Stem Cell Transplantation2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Fighting Cancer, with the Help of a StrangerOctober 4th, 2018
Hospital Affiliations
Memorial Sloan Kettering Cancer CenterNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
